patients and methods. This retrospective study evaluated patients (age, at least 18 years) with nosocomial pneumonia (S. maltophilia isolated from respiratory culture) who were seen at Kaohsiung Chang Gung Memorial Hospital over a 3-year period. A total of 406 patients (64% male, mean deviation, years; mean duration of hospital deviation, days) age ‫ע‬ standard 69.6 ‫ע‬ 14.93 stay ‫ע‬ standard 57.5 ‫ע‬ 39.47 were included.
results. Most index isolates (53.9%) were from the first sample cultured. Polymicrobial isolates were cultured from samples from 177 (43.6%) of the 406 study patients. The most common copathogen was Pseudomonas aeruginosa (53.11% of isolates). The all-cause hospital mortality rate was 42.6% (173 deaths among 406 patients). Survivors had a shorter time from admission to a positive index culture result than did nonsurvivors ( conclusions. S. maltophilia pneumonia is associated with a high mortality rate and is commonly associated with concomitant polymicrobial colonization or infection. Underlying comorbidities and inadequate initial empirical antibiotic therapy substantially account for increased mortality rates.
Nosocomial pneumonia, also termed hospital-acquired pneumonia (HAP), is the most common and leading cause of morbidity and mortality in hospitals when caused by multidrug-resistant strains that are unresponsive to initial antibiotic treatment. 1 Ventilator-associated pneumonia (VAP) refers to HAP that occurs in patients who require mechanical ventilation. Patients with HAP have a greater risk of mortality, compared with patients who receive mechanical ventilation and do not develop pneumonia. 2 The increase in the prevalence of HAP due to antibiotic-resistant bacteria has resulted in more frequent administration of inappropriate antimicrobial treatment and the associated increased risk of hospital mortality and increased medical care costs. [3] [4] [5] Many studies have investigated risk factors for and consequences of the development of nosocomial infection. However, because most of these studies did not systematically account for discharge status, such as all-cause mortality, potential for significant bias exists. 6 Stenotrophomonas maltophilia often presents as part of a polymicrobial culture and is usually not well established when treatment is indicated. 7 The incidence of S. maltophilia infection has increased in recent years, especially in immunocompromised and clinically debilitated patients. Infection due to multidrug-resistant S. maltophilia has emerged as an important nosocomial infection in many hospitals. [8] [9] [10] Risk factors, such as old age, poor physiological score, and bacteremia, have been found to increase mortality among patients with S. maltophilia infection. [11] [12] [13] Most of these studies focused only on a particular patient group, such as patients with cancer or patients staying in an intensive care unit (ICU). However, nosocomial pneumonia could occur in any patient and in any ward. Therefore, we conducted this study to review nosocomial pneumonia due to S. maltophilia in our hospital and to identify potential risk factors for mortality in these
patients. An understanding of the epidemiology, possible coinfecting pathogens, and antimicrobial susceptibility profile of nosocomial S. maltophilia pneumonia would provide insight into potential therapeutic approaches. 
Setting and Study Design
This was a retrospective study conducted at the Kaohsiung Chang Gung Memorial Hospital, a 2400-bed, tertiary teaching hospital in southern Taiwan. During a 3-year period (January 2005-December 2007), all hospitalized patients aged 18 years or older who had nosocomial S. maltophilia pneumonia microbiologically confirmed by sputum culture were recruited. Patients with known tuberculosis or severe immunosuppression, such as human immunodeficiency virus infection or solid organ or bone marrow transplantation, were excluded. In patients who had multiple episodes of pneumonia, only the first episode and its associated first sputum culture positive for S. maltophilia were used for the analysis. This study was approved by the Institutional Review Board of the Chang Gung Memorial Hospital, and the requirement for patient consent was waived.
Definitions
Pneumonia was defined in accordance with modified criteria proposed by the US Centers for Disease Control and Prevention. This definition requires 2 of the following criteria to be met: fever (increase in temperature of at least 1ЊC or body temperature greater than 38.3ЊC), leukocytosis (25% increase in leukocyte count and a leukocyte count of at least 10,000 cells/mm 3 ) or leukopenia (25% decrease in leukocyte count and a leukocyte count of no more than 5000 cells/ mm 3 ), and purulent tracheal secretions (more than 25 neutrophils per high-power field). The definition also requires one of the following criteria to be met: new and persistent infiltrates apparent on a chest radiograph, same microorganism isolated from pleural fluid and tracheal secretions, radiographic cavitation or histological evidence of pneumonia, or positive results of culture of bronchoalveolar lavage samples (greater than or equal to colony-forming units/ 4 1 # 10 mL). Pneumonia was considered to be hospital acquired if it occurred within 48 hours after hospital admission or if the patient was readmitted within 1 week after the last discharge from the hospital; VAP was defined as pneumonia that occurred within 48-72 hours after mechanical ventilation. Patients were classified as having an ICU stay if they were in the ICU when S. maltophilia was isolated from a sputum sample. Polymicrobial infection was defined as S. maltophilia isolated with a mixture of other microorganisms from the same respiratory sample. The susceptibilities of S. maltophilia isolates to antimicrobial agents were determined using the disk-diffusion methods, as recommended by the National Committee for Clinical Laboratory Standards.
14 Indeterminate susceptibility to antibiotics was considered to be drug resistance.
To evaluate the initial empirical antibiotic response for treating underlying pneumonia, we defined an antibiotic as adequate if it was able to cover pathogens isolated from culture, with clinically improving condition in the patient assessed at 48 hours after the start of treatment. Inadequate initial antibiotic treatment was defined as inability to cover any 1 bacterium and lack of improvement of the patient's clinical condition within 48 hours after the start of antibiotic treatment. If clinical status after initial antibiotic treatment could not be identified as adequate or inadequate, it was designated as indeterminate.
After use of antibiotics to treat pneumonia for 7 days, clinical status was re-evaluated and classified as improved if fever had subsided, sputum production had decreased, and there was regression of pneumonia infiltration on chest radiograph and improvement of laboratory data; otherwise, it was classified as not improved. If the clinical status could not be identified as improved or not improved, it was designated as indeterminate.
Data Collection
Clinical data were retrieved from medical and microbiology records and included age, sex, underlying disease or condition, duration of hospital stay, initial empirical antibiotic treatment, culture site, susceptibilities of antimicrobial agent, and discharge status. Comorbidity was quantified using the Charlson Comorbidity Index, as described elsewhere. 15 Bacteremia; stay in an ICU; invasive procedures, including those required for tracheostomy and mechanical ventilation; and any antibiotic use in the previous 14 days were considered as possible risk factors if performed or existing before onset of S. maltophilia pneumonia. The primary aim of this study was to determine the potential risk factors of in-hospital mortality. The risk factors for polymicrobial infection during hospitalization were also examined.
Statistical Analysis
Categorical variables were analyzed using the x 2 test or Fisher's exact test when appropriate, and continuous variables were compared using Student's t test or the Mann-Whitney U test. Multivariate logistic regression analyses were performed to identify risk factors for mortality and polymicrobial infection. Each variable considered to be a risk factor and with a P value !.20 in the univariate analysis was entered into the multivariate model. A backward elimination procedure was used to define the final independent risk factors. The Hosmer-Lemeshow test was used to assess goodness-of-fit. Cumulative mortality was estimated by the Kaplan-Meier analysis comparing patients with adequate and inadequate initial empirical antibiotic therapy. Difference in survival was calculated according to log-rank statistics.
Results are presented as absolute number (percentage) or mean ‫ע(‬ standard deviation). Adjusted odd ratios and 95% confidence intervals are reported for logistic regression analyses. A 2-tailed P value !.05 was considered to be statistically significant. All statistical analyses were performed using SPSS, version 14.0 (SPSS).
results

Patient Characteristics
Of the total 4084 patients with positive respiratory culture results during hospitalization who were initially evaluated during the 3-year study period, 406 met the inclusion criteria. Characteristics of the study patients are presented in Table 1 Table 2 .
Microbiology and Polymicrobial Infection
Respiratory cultures positive for S. maltophilia were obtained on day 28 after admission. Most S. maltophilia isolates (54%) were isolated from the first positive sample. Polymicrobial infections were found in 177 (43.6%) patients. P. aeruginosa was the most frequently found copathogen (in 94 samples [53.1%]), followed by Corynebacterium species, Staphylococcus aureus, and Acinetobacter baumannii (Table 3 ). In our study, polymicrobial infections were not associated with hospital mortality but were more common in patients with antibiotic use in the previous 14 days, resistance to ciprofloxacin, diabetes mellitus, chronic pulmonary disease, and tracheostomy (Table 4) . Furthermore, patients with polymicrobial infection had a longer hospital stay and tended to be infected for a longer period, compared with patients with monomicrobial infection. According to multivariate analysis, chronic pulmonary disease, resistance to ciprofloxacin, and tracheostomy were independent risk factors for polymicrobial infection with S. maltophilia (Table 5) . Table 6 shows the antibiotic susceptibility results for S. maltophilia isolates. The most effective antibiotics for S. maltophilia were levofloxacin and moxifloxacin. Among all isolates, the rates of resistance to flumarin, ciprofloxacin, and trimethoprim-sulfamethoxazole were 87.2%, 28.1%, and 16.3%, respectively. A slightly increasing trend in the rate of resistance to trimethoprim-sulfamethoxazole was observed. Of the 406 study patients, 7 (1.7%) had multidrug-resistant S. maltophilia infection. There were no statistically significant differences in susceptibility patterns between the monomicrobial and polymicrobial groups. Because our results revealed that a significant proportion of coinfection was attributable to P. aeruginosa, we examined the antibiotic susceptibility for P. aeruginosa isolates and found that the most effective antibiotic for both S. maltophilia and P. aeruginosa was levofloxacin, followed by ciprofloxacin.
Antimicrobial Susceptibility
Mortality
The all-cause hospital mortality rate was 43% (173 deaths), and 90 patients died within 14 days after the onset of S. maltophilia pneumonia. There was no statistically significant difference in mean overall duration of hospital stay between survivors and nonsurvivors, but survivors had a shorter duration of hospital stay before pneumonia onset and a longer duration of hospital stay after pneumonia onset. Mortality was significantly higher among male patients, patients who stayed in an ICU, patients with a greater Charlson Comorbidity Index score, and patients with malignancy or renal disease. Adequacy of initial empirical antibiotic therapy and improvement of pneumonia status within 7 days after initiation of treatment resulted in a good outcome. Multivariate analysis revealed that ICU stay, malignancy, renal disease, and inadequate initial empirical antibiotic therapy were independent risk factors for hospital mortality (Table 5) , and diabetes mellitus seemed to provide some survival benefit protection. Adequate initial empirical antibiotic therapy also resulted in better outcome than did inadequate antibiotic therapy during the hospital stay, as assessed by the Kaplan-Meier method ( Figure 1 ). Mortality was slightly higher in the monomicrobial group than in the polymicrobial group (45.85% vs 38.42%; P p ). There was no difference in the rate of VAP between .133 the groups ( ); however, VAP was associated with P p .236 higher mortality in the monomicrobial group but not in the polymicrobial group. Adequate initial empirical antibiotic therapy affected patient outcome in the polymicrobial group but not in the monomicrobial group. Improved pneumonia status within 7 days after initiation of treatment resulted in better survival rates in both groups. The use of trimethoprimsulfamethoxazole in the monomicrobial group and quinolones in the polymicrobial group as initial empirical antibiotic therapy contributed to good outcomes (Table 2 ). Multivariate analysis revealed that ICU stay, malignancy, and renal disease were independent risk factors for hospital mortality in the monomicrobial group and that only malignancy and renal disease were mortality risk factors in the polymicrobial group.
discussion
Our study has 3 main findings. First, HAP due to S. maltophilia is associated with high mortality. Second, P. aeruginosa was commonly seen in polymicrobial cultures positive for S. maltophilia. Third, mortality was significantly higher among male patients and patients who required an ICU stay, had a high Charlson Comorbidity Index score, had malignancy or renal disease, or received inadequate initial empirical antibiotic treatment.
S. maltophilia is an important nosocomial pathogen that has been responsible for an increasing frequency of infection in recent years, especially in immunocompromised and clinically debilitated patients. As was shown in recent studies, severe infection caused by S. maltophilia is associated with a high mortality rate (41%-62%). [16] [17] [18] S. maltophilia pneumonia-associated mortality was previously reported to be 23%-44% 12, 19 and was 42.6% in the present study. Unlike most of the previous studies, our study not only included patients from both the general ward and the ICU but also did not exclude patients with polymicrobial infection. In our study, we found that polymicrobial infection was common in nosocomial pneumonia caused by S. maltophilia, and P. aeruginosa was the most frequently found copathogen. Similar to figure 1. Kaplan-Meier survival curves for patients who received adequate empirical antibiotic therapy and patients who received inadequate empirical antibiotic therapy for nosocomial Stenotrophomonas maltophilia pneumonia.
, by log-rank test. P ! .001 other study findings, 20 our results showed that polymicrobial infection was not associated with hospital mortality. Strains of S. maltophilia have been reported to transfer antibiotic resistance to other bacteria, such as P. aeruginosa, Enterobacteriaceae species, and Proteus mirabilis. [21] [22] [23] Therefore, the presence of S. maltophilia in polymicrobial infection deserves attention, and we suggest that antibiotics chosen for the treatment of S. maltophilia pneumonia should also cover P. aeruginosa. Some researchers may consider studies excluding polymicrobial infections to be cleaner; however, we chose to include polymicrobial infections because we encounter many such cases in clinical practice. Especially in our study, we found that inadequate initial antibiotic treatment (unable to cover any bacterium isolated from culture) may result in higher mortality in the group with polymicrobial infection than in the group with monomicrobial infection. This prompted us to consider all pathogens.
As suggested in most of the previous studies, malignancy, severe septic shock, and organ failure were independent risk factors for mortality associated with S. maltophilia infection. 24, 25 Del Toro et al directly indicated that mortality is highly correlated with the severity of the baseline situation. 26 Therefore, it was not surprising that our study found that malignancy, renal disease, and ICU stay were the independent risk factors for mortality among patients with nosocomial S. maltophilia pneumonia. However, an interesting finding in our study was that diabetes mellitus was associated with a lower mortality risk, which is in discordance with other reports. 27, 28 We cannot find a better explanation than chance for this finding. This result could have also been obscured by use of the diagnosis of diabetes from the chart abstract data in the analysis, which failed to accurately reflect the blood glucose level at the time of infection. Further investigation of glycemic control status might be necessary to clarify the significance of this factor.
Mechanical ventilation is used for patients with acute respiratory failure, and those patients were at high risk of infection. Thus, pneumonia occurring after intubation with mechanical ventilation (VAP) may have a worse outcome. We identified patients with VAP in the cohort of patients with S. maltophilia pneumonia and assessed whether this factor affected the outcome. We found that the mortality rate was higher among patients with S. maltophilia VAP than among with patients with HAP who did not receive mechanical ventilation; however, the difference did not reach statistical significance ( ). When patients were grouped in mon-P p .09 omicrobial and polymicrobial groups, we found that there was a statistically significant difference in mortality between the group with VAP and the group with HAP not associated with mechanical ventilation in the monomicrobial group but not in the polymicrobial group. Tracheostomy can enable collection of a lower respiratory tract specimen for culture without contamination by normal flora of the oral cavity, but its effect on pneumonia outcomes remains controversial. Several authors have demonstrated that tracheostomy may decrease the risk of VAP, 29, 30 although others have reported the opposite finding. 12 In our study, tracheostomy was shown to have a potential protective effect with borderline statistical significance in univariate analysis but no significance in multivariate analysis. A possible explanation for this finding could be the compounding effects of other factors.
Early and adequate antibiotic therapy is important to optimize the treatment of patients with HAP. 5, 14, [31] [32] [33] In other words, the appropriateness of initial antibiotic therapy is very important in patients with pneumonia, especially those with HAP caused by an antibiotic-resistant pathogen. Kollef et al indicated that inappropriate initial antibiotic therapy of microbiologically confirmed VAP was associated with greater 30-day mortality. 5 In our study, the adequacy of initial empirical antibiotic therapy was correlated with hospital survival among all patients with S. maltophilia pneumonia, and inadequate initial empirical antibiotic therapy was the independent factor for predicting hospital mortality by multivariate analysis. We also found that better outcomes may occur in patients with S. maltophilia pneumonia when sputum specimens are cultured as early as possible. Sputum culture may not only identify the pathogen causing pneumonia but may also guide clinicians to administer the most effective antibiotic treatment.
Trimethoprim-sulfamethoxazole is a therapeutic option for S. maltophilia infection and has frequently been prescribed, as suggested by several reports. [34] [35] [36] [37] However, the rate of resistance to this antibiotic has increased in recent years. [38] [39] [40] [41] Trimethoprim-sulfamethoxazole is not a favorable drug to treat infection with nosocomial pathogens other than S. maltophilia. If patients with S. maltophilia pneumonia are coinfected with other pathogens, this drug may fail to treat nosocomial pneumonia. However, trimethoprim-sulfamethoxazole may contribute to treatment benefit and result in a good survival rate for monomicrobial (S. maltophilia only) infections. Quinolone was the most reliable antibiotic in the polymicrobial group. Therefore, we suggest that trimethoprimsulfamethoxazole would still be beneficial in treating monomicrobial S. maltophilia pneumonia. However, when taking polymicrobial S. maltophilia pneumonia into consideration, we suggest that all pathogens should be carefully identified to exclude colonized isolates and to assess the clinical condition before antibiotic administration. As shown in our study, patients with S. maltophilia pneumonia may be coinfected with P. aeruginosa, and treatment with levofloxacin or ciprofloxacin may result in good outcomes in patients with this polymicrobial infection.
The strengths of the present study are its relatively large sample of unselected patients and detailed collection of clinical data; furthermore, its retrospective design was primarily aimed at generating hypotheses for future studies. However, this study has several limitations. First, we did not investigate the precise cause of death in our patients but used hospital mortality instead. Indeed, it is difficult to differentiate deaths directly due to S. maltophilia infection from those that are the result of comorbidities or presence of other pathogens. However, improvement of pneumonia status within 7 days after the initiation of treatment may attenuate the hospital mortality rate, which suggests that S. maltophilia infection may have a large influence on hospital mortality. Second, we may have missed a certain percentage of infections detected using other methods, including protected specimen brush and bronchoalveolar lavage fluid analysis, for the diagnosis of S. maltophilia pneumonia. However, in our hospital, culture of sputum and endotracheal aspirate specimens are the most frequently used diagnostic methods for patients with suspected pulmonary infection. Third, polymicrobial infections may be mixed with colonized isolates, and we lacked direct evidence to prove that all bacteria were true pathogens, although adequate antibiotics to manage all isolated bacteria may result in good outcomes.
In conclusion, we suggest that S. maltophilia HAP may result in high mortality. Underlying conditions of malignancy or renal disease, ICU stay, and inadequate initial empirical antibiotic treatment may result in poor outcomes. Polymicrobial infections are common, especially in patients with chronic pulmonary disease and tracheostomy. S. maltophilia pneumonia frequently co-occurs with P. aeruginosa, and antibiotic treatment to cover both pathogens may be needed.
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